Related Experiment Video
Updated: Dec 22, 2025

Utilizing the Precision-Cut Lung Slice to Study the Contractile Regulation of Airway and Intrapulmonary Arterial Smooth Muscle
Published on: May 5, 2022
Class C GPCRs in the airway
Brijeshkumar S Patel1, Jovanka Ravix1, Christina Pabelick2
1Department of Anesthesiologyand Perioperative Medicine, Mayo Clinic, Rochester, MN, United States.
Abstract:
Understanding and targeting of GPCRs remain a critical aspect of airway pharmacology and therapeutics for diseases such as asthma or COPD. Most attention has been on the large Class A GPCRs towards improved bronchodilation and blunting of remodeling. Better known in the central or peripheral nervous system, there is increasing evidence that Class C GPCRs which include metabotropic glutamate and GABA receptors, the calcium sensing receptor, sweet/umami taste receptors and a number of orphan receptors, can contribute to airway structure and function. In this review, we will summarize current state of knowledge regarding the pharmacology of Class C GPCRs, their expression and potential functions in the airways, and the application of pharmacological agents targeting this group in the context of airway diseases.
Insights
Class C G-protein coupled receptors (GPCRs) are emerging targets in airway pharmacology. This review explores their role in respiratory diseases like asthma and COPD, offering new therapeutic avenues.
Area of Science:
- Respiratory pharmacology
- G-protein coupled receptor (GPCR) research
- Airway disease therapeutics
Background:
- G-protein coupled receptors (GPCRs) are crucial in airway function and disease.
- Class A GPCRs are well-studied for bronchodilation and remodeling in asthma and COPD.
- Class C GPCRs, including glutamate and GABA receptors, are increasingly recognized for their role in airway physiology.
Purpose of the Study:
- To review the current knowledge on Class C GPCRs in airway pharmacology.
- To discuss the expression, function, and therapeutic potential of Class C GPCRs in airway diseases.
- To highlight the application of targeting Class C GPCRs for conditions like asthma and COPD.
Main Methods:
- Literature review of Class C GPCRs in airway research.
- Analysis of pharmacological data and expression patterns.
- Synthesis of findings on therapeutic applications.
Main Results:
- Class C GPCRs are expressed in the airways and influence structure and function.
- Evidence suggests their involvement in respiratory diseases.
- Pharmacological targeting of Class C GPCRs presents novel therapeutic opportunities.
Conclusions:
- Class C GPCRs represent a promising, yet underexplored, area for airway disease treatment.
- Further research into their specific roles and targeted agents is warranted.
- Targeting Class C GPCRs could lead to improved therapies for asthma and COPD.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Gross Anatomy of the Lungs
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

